FR2343752A1 - Complexes alcooliques du phosphate d'estramustine, leur preparation et leur application a titre d'intermediaires dans la purification de ce compose et de ses sels - Google Patents

Complexes alcooliques du phosphate d'estramustine, leur preparation et leur application a titre d'intermediaires dans la purification de ce compose et de ses sels

Info

Publication number
FR2343752A1
FR2343752A1 FR7707129A FR7707129A FR2343752A1 FR 2343752 A1 FR2343752 A1 FR 2343752A1 FR 7707129 A FR7707129 A FR 7707129A FR 7707129 A FR7707129 A FR 7707129A FR 2343752 A1 FR2343752 A1 FR 2343752A1
Authority
FR
France
Prior art keywords
intermediaries
purification
salts
compound
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7707129A
Other languages
English (en)
French (fr)
Other versions
FR2343752B1 (US06256357-20010703-M00001.png
Inventor
Sten Krister Kristenssen
Anders Robert Stamvik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo AB
Original Assignee
Leo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo AB filed Critical Leo AB
Publication of FR2343752A1 publication Critical patent/FR2343752A1/fr
Application granted granted Critical
Publication of FR2343752B1 publication Critical patent/FR2343752B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7707129A 1976-03-10 1977-03-10 Complexes alcooliques du phosphate d'estramustine, leur preparation et leur application a titre d'intermediaires dans la purification de ce compose et de ses sels Granted FR2343752A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9451/76A GB1523035A (en) 1976-03-10 1976-03-10 Derivatives of estradiol - 17 - dihydrogen phosphates

Publications (2)

Publication Number Publication Date
FR2343752A1 true FR2343752A1 (fr) 1977-10-07
FR2343752B1 FR2343752B1 (US06256357-20010703-M00001.png) 1978-10-20

Family

ID=9872205

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7707129A Granted FR2343752A1 (fr) 1976-03-10 1977-03-10 Complexes alcooliques du phosphate d'estramustine, leur preparation et leur application a titre d'intermediaires dans la purification de ce compose et de ses sels

Country Status (17)

Country Link
US (1) US4115414A (US06256357-20010703-M00001.png)
JP (2) JPS52108963A (US06256357-20010703-M00001.png)
AT (1) AT355737B (US06256357-20010703-M00001.png)
BE (1) BE852271A (US06256357-20010703-M00001.png)
CA (1) CA1083140A (US06256357-20010703-M00001.png)
CH (1) CH633813A5 (US06256357-20010703-M00001.png)
DE (1) DE2710293C2 (US06256357-20010703-M00001.png)
DK (1) DK156007C (US06256357-20010703-M00001.png)
FR (1) FR2343752A1 (US06256357-20010703-M00001.png)
GB (1) GB1523035A (US06256357-20010703-M00001.png)
IE (1) IE45024B1 (US06256357-20010703-M00001.png)
IL (1) IL51592A (US06256357-20010703-M00001.png)
IT (1) IT1075668B (US06256357-20010703-M00001.png)
LU (1) LU76927A1 (US06256357-20010703-M00001.png)
MX (1) MX5242E (US06256357-20010703-M00001.png)
NL (1) NL7702608A (US06256357-20010703-M00001.png)
SE (1) SE428928B (US06256357-20010703-M00001.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0612760A2 (en) * 1993-02-18 1994-08-31 Permachem Asia, Ltd. Method for purification of estramustin phosphate or salt thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040255A (en) * 1996-06-25 2000-03-21 Kimberly-Clark Worldwide, Inc. Photostabilization package usable in nonwoven fabrics and nonwoven fabrics containing same
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
GB9921958D0 (en) * 1999-09-16 1999-11-17 Pharmacia & Upjohn Spa Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3299104A (en) 1963-04-09 1967-01-17 Leo Ab Certain steroid nu-bis-(haloethyl)-carbamates
GB1458372A (en) * 1973-03-05 1976-12-15 Leo Ab Steroid carbamates and allophanates

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0612760A2 (en) * 1993-02-18 1994-08-31 Permachem Asia, Ltd. Method for purification of estramustin phosphate or salt thereof
EP0612760A3 (en) * 1993-02-18 1995-08-30 Permachem Asia Ltd Process for the purification of estramustin phosphate or its salts.

Also Published As

Publication number Publication date
JPS5526160B2 (US06256357-20010703-M00001.png) 1980-07-11
DK103577A (da) 1977-09-11
LU76927A1 (US06256357-20010703-M00001.png) 1978-10-18
GB1523035A (en) 1978-08-31
IL51592A0 (en) 1977-05-31
DE2710293A1 (de) 1977-09-15
JPS5589300A (en) 1980-07-05
BE852271A (fr) 1977-09-09
AT355737B (de) 1980-03-25
US4115414A (en) 1978-09-19
MX5242E (es) 1983-05-16
DK156007C (da) 1989-11-06
DK156007B (da) 1989-06-12
ATA157777A (de) 1979-08-15
IT1075668B (it) 1985-04-22
SE7702613L (sv) 1977-09-11
CA1083140A (en) 1980-08-05
FR2343752B1 (US06256357-20010703-M00001.png) 1978-10-20
IE45024B1 (en) 1982-06-02
SE428928B (sv) 1983-08-01
IE45024L (en) 1977-09-10
JPS5755720B2 (US06256357-20010703-M00001.png) 1982-11-25
NL7702608A (nl) 1977-09-13
CH633813A5 (de) 1982-12-31
DE2710293C2 (de) 1986-06-12
IL51592A (en) 1980-09-16
JPS52108963A (en) 1977-09-12

Similar Documents

Publication Publication Date Title
DE3767557D1 (de) Einkristalline koerper aus superlegierungen.
PT72049B (pt) Imidazole-5-acetic acid derivatives their production and use
IT1199837B (it) Metodi per la preparazione di medicazioni
BR8008493A (pt) Processo de preparacao de composicoes farmaceuticas contendo corticoesteroides e esteres de l-arginina soluveis na agua, e composicao assim obtida
IT8423449A0 (it) Indicatori stabilizzati per rivelare l'attivita' di enzimi e procedimenti per la loro preparazione ed uso.
DK326587A (da) Topisk farmaceutisk praeparat med systemisk virkning
DK683987D0 (da) Topisk farmaceutisk praeparat til anvendelse i form af tape
IT1093686B (it) Complessi di ammino-acido-acido mandelico otticamente attivi e relativo al procedimento di preparazione
IT1131988B (it) Procedimento per migliorare la proprieta' di leghe
FR2351942A1 (fr) Derives d'acide acetyl-3 dimethyl-2,2 cyclopropanecarboxylique utilisables dans la preparation d'insecticides
FR2343752A1 (fr) Complexes alcooliques du phosphate d'estramustine, leur preparation et leur application a titre d'intermediaires dans la purification de ce compose et de ses sels
FI890477A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi
IT1191173B (it) Composto e composizione farmaceutica per accelerare la cicatrizzazione di ferite
BE840513A (fr) Triisocyanates utilisables dans la preparation de resines de polyurethannes
DK482287A (da) Topisk antiinflammatorisk praeparat
IT1128567B (it) Complessi cromiferi asimmetrici 1:2 loro preparazione e loro impiego come coloranti
ES497916A0 (es) Perfeccionamientos en la fabricacion de placas reflectantes en multiples direcciones
BE836621A (fr) Agents ugnifugeants phosphores utilisables dans la preparation de polyurethanes
BE839258A (fr) Perfectionnements a la preparation d'alliages
IT1082140B (it) Fosfiti di polialcooli stabili all'idrolisi,loro preparazione e loro uso
GB8700593D0 (en) Deuterated l-arginine phosphate monohydrate
BR8804252A (pt) Composicao antisseptica ou anti-fungos soluvel em agua
FR2305412A1 (fr) Procede de preparation d'a-phenylglycines optiquement actives et composes intermediaires dans ledit procede
JPS5448711A (en) Racemization of optical active nnacyllamino acid in the atate of aqueous solution
AU515706B2 (en) Staphylococcus epidermis std: anti-cancer agent

Legal Events

Date Code Title Description
ST Notification of lapse